BIBLIOGRAFIA - Atrofia Muscolare Spinale (SMA)
- Linee guida per la riabilitazione delle malattie neuromuscolari infantili di origine genetica. G di Neuropsicofarmacol.
- Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care-NC-ND license. Neuromuscul Disord. 2018;
- Il- EB V, Th M. Dossier Spinraza Piemonte. 2017.
- Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018 Mar 1;
- Sumner CJ, Paushkin S, Ko C. Spinal muscular atrophy : disease mechanisms and therapy.
- D’Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Vol. 6, Orphanet journal of rare diseases. BioMed Central; 2011. 71 p.
- Arnold ES, Fischbeck KH. Spinal muscular atrophy. Handb Clin Neurol. 2018;591–601.
- Riassunto delle caratteristiche del prodotto. Epidemiol Psichiatr Soc.
- SMA, risultati clinici incoraggianti da olesoxime - Osservatorio Malattie Rare.
- Messina S. New Directions for SMA Therapy. J Clin Med. 2018 Aug 31;
- Prakash V. Spinraza-a rare disease success story. Gene Ther. 2017 Sep;
- Gidaro T, Servais L. Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps. Dev Med Child Neurol. 2019;
- Mastella C, Ottonello G. “SMA1 abita con noi”. Vademecum per una sostenibile vita quotidiana a casa. 2009.
- Smartnet P. HFMSE Manual. 2009.
- De Sanctis R, Coratti G, Pasternak A, Montes J, Pane M, Mazzone ES, et al. Developmental milestones in type I spinal muscular atrophy. Neuromuscul Disord. 2016;26:754–9.
- Glanzman AM et A. Chop Intend manuale. Medicina. 2010.
- Evaluator LC. Revised Upper Limb Module for SMA. 2014;1–21.
- Bérard C, Payan C, Hodgkinson I, Fermanian J. A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15:463–70.